Business Context and Reporting Period
Company: ILLUMINA, INC. (ILMN)
Filing Type: Form 8-K (Current Report)
Date of Report: January 14, 2025
Reporting Period: Fourth quarter and fiscal year ended December 29, 2024
Context: This filing announces the issuance of a press release containing unaudited preliminary financial results in advance of a presentation at the J.P. Morgan Healthcare Conference.
Key Financial Metrics
The provided text serves as a cover document referencing a press release (Exhibit 99.1) but does not contain specific financial data. The filing text does not provide clear values for:
- Revenue
- Profit or Net Income
- Cash Flow
- Margins
- Debt Levels
- Liquidity Metrics
Material Changes
The filing text does not provide specific data regarding material changes versus the prior comparable period. Investors must refer to the attached press release (Exhibit 99.1) for comparative analysis.
Guidance, Outlook, and Risks
Management Commentary: The Company issued a press release regarding preliminary results and hosted a webcast presentation at the J.P. Morgan Healthcare Conference.
Legal Disclaimer: The information furnished in this Item 2.02 and Exhibit 99.1 is not deemed "filed" under Section 18 of the Exchange Act and is not subject to the liabilities of that Section. It shall not be incorporated by reference into any other filings under the Securities Act or Exchange Act.
Risks/Contingencies: No specific risks or contingencies are detailed in the text of this 8-K form.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for the actual unaudited preliminary financial figures for Q4 and FY 2024.
- Access the webcast presentation on the Company's Investor Relations website for detailed management commentary.
- Verify the "unaudited" status of the preliminary results before making investment decisions.
- Note that this specific 8-K text does not constitute a filed financial statement under Section 18 of the Exchange Act.